Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Cipla
Johnson and Johnson
Federal Trade Commission
Chinese Patent Office
Julphar
Argus Health
Harvard Business School

Generated: July 16, 2018

DrugPatentWatch Database Preview

DIHYDROERGOTAMINE MESYLATE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for dihydroergotamine mesylate and what is the scope of dihydroergotamine mesylate freedom to operate?

Dihydroergotamine mesylate
is the generic ingredient in four branded drugs marketed by Valeant, Hikma Pharms, Paddock Llc, Sagent Pharms, West-ward Pharms Int, and Novartis, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for dihydroergotamine mesylate. Six suppliers are listed for this compound.
Pharmacology for DIHYDROERGOTAMINE MESYLATE
Ingredient-typeErgotamines
Drug ClassErgotamine Derivative
Medical Subject Heading (MeSH) Categories for DIHYDROERGOTAMINE MESYLATE
Synonyms for DIHYDROERGOTAMINE MESYLATE
(10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman mesylate
(10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman methanesulfonate
(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-BENZYL-2-HYDROXY-4-METHYL-5,8-DIOXO-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0(2),?]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),9,12,14-TETRAENE-4-CARBOXAMIDE; METHA
(4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carboxamide; metha
(4R,7R)-N-[(1S,2S,4R,7S)-7-BENZYL-2-HYDROXY-4-METHYL-5,8-DIOXO-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0(2),?]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),9,12,14-TETRAENE-4-CARBOXAMIDE; METHANES
(6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-Benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxa
(6aR,9R)-N-((2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide methanesulfonate
11032-41-0
511-12-6 (Parent)
6190-39-2
81AXN7R2QT
9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotaman-3',6',18-trione mesylate
9,10-Dihydroergotamine mesylate
9,10-dihydroergotamine methanesulfonate
910882-41-6
AC1L2FO7
AC1LAOVT
AC1Q6WD6
ADYPXRFPBQGGAH-UMYZUSPBSA-N
AKOS024282478
AN-21195
ANW-42737
C33H37N5O5.CH4O3S
CCG-39548
CHEBI:59756
CHEMBL1200517
CHEMBL1396675
CS-2903
CTK8B3562
D 2763
D.H.E. 45
D02211
D0SP3D
D2633
DETMS
DHE-45
Dihydergot
Dihydroergotamine (mesylate)
Dihydroergotamine for peak identification, European Pharmacopoeia (EP) Reference Standard
Dihydroergotamine mesilate
Dihydroergotamine mesilate (JP17)
Dihydroergotamine mesilate, European Pharmacopoeia (EP) Reference Standard
Dihydroergotamine mesylate (USP)
Dihydroergotamine mesylate [USAN:USP]
Dihydroergotamine mesylate [USAN]
Dihydroergotamine mesylate, United States Pharmacopeia (USP) Reference Standard
Dihydroergotamine methanesulfonate
Dihydroergotamine methanesulfonate salt
Dihydroergotamine methanesulfonate salt, powder
Dihydroergotamine monomethanesulfonate
DIHYDROERGOTAMINE; METHANESULFONIC ACID
Dihydroergotoxin
DIHYDROERGOTOXINE
Dihytamine
DR003475
DR003476
EINECS 228-235-6
Ergoloid dihydroergotoxine
Ergoloid Mesylates (dihydroergotoxine)
Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy- 2'-methyl-5'-(phenylmethyl)-, (5'?,10?)-, monomethanesulfonate (salt)
Ergotamine, 9,10-dihydro-, monomethanesulfonate (salt)
Ergotamine, dihydro, methanesulfonate (salt)
Ergotoman-3',6',18-trione,9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, monomethanesulfonate (salt)
EU-0100357
HMS1920G16
HMS2094K05
HMS2231H03
HMS3261G15
HMS3266C22
HMS3369K10
HMS501N14
HY-B0670A
I14-101170
LP00357
LS-64558
MFCD00058615
mide methanesulfonate
MLS002153175
MLS002207048
MolPort-003-666-163
MT 300
N-{7-BENZYL-2-HYDROXY-4-METHYL-5,8-DIOXO-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0(2),?]DODECAN-4-YL}-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),9,12,14-TETRAENE-4-CARBOXAMIDE; METHANESULFONIC ACID
NCGC00261042-01
Neomigran
NSC-759848
NSC759848
Pharmakon1600-01500248
PL001844
PL041420
PL057923
Prestwick_746
rboxamide methanesulfonate(salt)
SCHEMBL40843
SCHEMBL40844
SMR001230668
SPECTRUM1500248
SR-01000075382
SR-01000075382-1
ST056346
Tox21_500357
TR-021291
TRA0034972
UNII-81AXN7R2QT
Z1544404034

US Patents and Regulatory Information for DIHYDROERGOTAMINE MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int DIHYDROERGOTAMINE MESYLATE dihydroergotamine mesylate INJECTABLE;INJECTION 040453-001 Jun 9, 2003 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-002 Nov 30, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant D.H.E. 45 dihydroergotamine mesylate INJECTABLE;INJECTION 005929-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for DIHYDROERGOTAMINE MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Merck
UBS
Queensland Health
Cerilliant
Fish and Richardson
QuintilesIMS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.